Extremely low levels of epidermal skin-derived antileucoproteinase/elafin in a patient with impetigo herpetiformis
- 1 July 1997
- journal article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 137 (1) , 123-129
- https://doi.org/10.1111/j.1365-2133.1997.tb03714.x
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Constitutive and inducible expression of SKALP/elafin provides anti-elastase defense in human epithelia.Journal of Clinical Investigation, 1996
- Levels of Skin-Derived Antileukoproteinase (SKALP)/Elafin in Serum Correlate with Disease Activity During Treatment of Severe Psoriasis with Cyclosporin AJournal of Investigative Dermatology, 1995
- Demonstration of Skin-Derived Antileukoproteinase (SKALP) in Urine of Psoriatic PatientsJournal of Investigative Dermatology, 1992
- Hypocalcemia in impetigo herpetiformis: a secondary transient phenomenon?Archives of Dermatology, 1991
- Elafin is a potent inhibitor of proteinase 3Biochemical and Biophysical Research Communications, 1991
- Impetigo herpetiformis associated with hypocalcemia of congenital ricketsArchives of Dermatology, 1991
- Skin-derived antileucoproteases (SKALPs): characterization of two new elastase inhibitors from psoriatic epidermisBritish Journal of Dermatology, 1990
- Impetigo herpetiformis: A variant of pustular psoriasis or a separate entity?Journal of the American Academy of Dermatology, 1989
- Monocyte and neutrophil chemotaxis in psoriasis: Relation to the clinical status and the type of psoriasisJournal of the American Academy of Dermatology, 1986
- PSORIASIS AND HYPOPARATHYROIDISM.British Journal of Dermatology, 1963